Study design: Randomized, double-blinded animal experiment for neural functional recovery from spinal cord injury (SCI) through vaccination with immature dendritic cells (DCs) pulsed with homogenate protein of spinal cord (hpDCs) in mice. Objective: To study the effect of hpDCs in the recovery from SCI in mice. Method: Immature DCs pulsed with homogenate protein of spinal cord, myelin basic protein (MBP) or phosphate-buffer solution (PBS) were injected into spinal cord-injured mice locally or peritoneally. The functional recovery of spinal cord (open-field locomotor rating scale of Basso, Beattie and Bresnahan, BBB score) was measured weekly. The areas of injured region and cyst as well as the thickness of the glial scar were measured and the expressions of glial fibrillary acidic protein, neurofilament and nestin were detected to confirm the BBB scores. Results: Eighty-four days after injection, the BBB score of the hpDCs group (peritoneally injected mice) reached 18.2±1.1, significantly higher than that the scores of the mbpDCs and control groups (16.3 ± 2.1 and 10.0 ± 2.0, respectively). The areas of injured region and cyst as well as the thickness of the glial scar of the hpDCs group were less than that of the control group. Meanwhile, the expression of nestin lasts up to 56 days after injection in the hpDCs group, while it disappeared in the mbpDCs and PBS groups. Conclusion: Implanting DCs pulsed with homogenate protein of spinal cord, but not mbpDCs or PBS alone, locally or peritoneally, have a significant effect on functional recovery and neural preservation from SCI.
Introduction
The devastating outcomes of spinal cord injury (SCI) result from direct as well as secondary damage to neurons and fibers in the injured site. The secondary damage is caused mainly by the activity of injury-evoked destructive selfcompounds, such as physiological substances with an excess of toxin over their normal levels or degradation products of self-compounds. 1 Thus, neuroprotection of the spared neurons and regeneration of the damaged fibers may improve the functional recovery from SCI. 2, 3 Studies have indicated that a properly controlled T cellsmediated, antigen-specific immunity in SCI has a pivotal function in regrowth of the injured spinal cord and its protection from secondary degeneration. Passive or active immunization with T cells specific to central nervous systemassociated myelin antigens reduces secondary degeneration in rat and mouse models of optic nerve crush or spinal cord contusion. 4, 5 Moreover, local implantation of macrophages activated by an autologous sciatic nerve improves the functional recovery in a completely transected spinal cord or an optic nerve because of regenerative growth. 6 Dendritic cells (DCs) are immune cells whose principal function is antigen presentation. 7 Their capacity of immune regulation is determined by the state of maturation as well as the number and context in which they are activated. The decisive signal is the expression of CD86 (B7-2) and MHC class II (MHC-II) molecules concurrently with the release of proinflammatory cytokines, especially interleukin-12, interleukin-6 and tumor necrosis factor-a from the DCs. A study indicates that vaccination with DCs pulsed with myelin basic protein (MBP) or peptides derived from MBP can improve functional recovery from SCI in rats, although the mechanism is unclear. 8 Homogenate protein of spinal cord, which is easy to prepare, contains all kinds of autoimmune antigens theoretically, if it is true. The purpose of this study is to find out whether immature DCs pulsed with homogenate protein of spinal cord (hpDCs) could improve functional recovery from SCI in mice and to compare their effect with immature DCs pulsed with MBP (mbpDCs).
Materials and methods

Animals
Adult BALB/c mice (4-6 weeks old, 18-23 g) were supplied by the Animal Breeding Center of Third Military Medical University (Chongqing, PR China). They were housed in a light-and temperature-controlled room and matched for age. All animals were handled according to guidelines of the National Institutes of Health and Third Military Medical University for the management of laboratory animals. We certified that all applicable institutional and governmental regulations concerning the ethical use of animals were followed during the course of this research.
Spinal cord injury
According to Fehlings' method, 9 all the mice were anesthetized by intraperitoneal injection of 10% chloral hydrate (5 ml kg
À1
), and the spinal cord was exposed by laminectomy at the level of T10. The spinal cord at the T10 level was clamped vertically to the longitudinal axis of the spinal cord by a microsurgery artery clamp (pressure is 2 g), which resulted in severe injury.
Antigens
A homogenate of the spinal cord was harvested from BALB/c mice (aged 4-6 weeks, weighing 18-23 g). The brief process is described as follows: BALB/c mice were killed by overdose anesthesia and T7-10 were sectioned. The spinal cord segments were ground and filtered (200 mm), then ground by an ultrasonic homogenizer, and finally centrifuged at 15 000 r.p.m. for 20 min. The supernatant was collected and the concentration of protein was measured. The concentration of total protein used here was 1 mg ml
À1
. MBP was bought from Sigma Company (St Louis, MO, USA).
Preparation of mouse DCs
Dendritic cells were obtained from bone marrow by a method described earlier 10 with some modifications. The brief process is described as follows: femurs and tibias were removed from the dead mature male BALB/c mice ( , were added on day 0. On days 2 and 4, the culture medium was replaced by DC medium supplemented with cytokines, and the floating cells were discarded. On day 7, the cells were collected with a cell scraper (Sarstedt, Newton, NC, USA) for adherent cells and centrifuged, and the pellet was resuspended in fresh DC medium (without adding cytokines; 2 Â 10 6 cells ml 
Experimental protocol for DC administration
The first evaluation of an open-field locomotor rating scale of Basso, Beattie and Bresnahan (BBB score) was carried out when the clamped mice resuscitated completely from anesthesia (about 4 h after surgery), and the inclusion criterion was BBB score o2. Three groups were established as the hpDCs group, mbpDCs group and PBS group, and each group was divided into two subgroups according to the injection site (lesion site or peritoneum). Cells (hpDCs or mbpDCs) were adjusted to the appropriate number and volume just before injection. For local injection, the wound was reopened and the mouse was fixed on a stereotaxic apparatus (Reward, China). Cells were injected into the center of lesion and the depth of injection was 0.5 mm using a Hamilton syringe. The wound was sutured when the injection was accomplished. For peritoneal injection, cells were injected into the peritoneum at the site of the right mid-abdomen. All injections were undertaken 24 h after SCI, and the concentrations of cells were recorded. The control mice were injected locally or peritoneally as described above with the same volume of PBS as the treated mice.
Assessment of functional recovery from spinal cord contusion
Functional recovery was determined by BBB score on a scale of 0 (complete paralysis) to 21 (normal mobility). Blind Retrograde labeling of axons At 84 days after injection, three mice from each group were reanesthetized, and spinal canal of T12 was opened as mentioned above. Horseradish peroxidase (Xitang biocompany, Shanghai, China) was applied below the site of contusion at T12. 11 The number of stained axons in the proximal spinal cord was taken to represent the number of intact axons ascending from the distal end and traversing the area of contusion. 12 After 5 days, the mice were again deeply anesthetized, and their spinal cords proximal to the lesion sites were excised and made into paraffin sections. All sections (5 mm) taken from the spinal cord were analyzed by DAB-niekel sulfate amine staining. The total number of labeled axons was counted in each section.
Antegrade labeling of axons
The mice were also subjected to antegrade labeling of axons with biotinylated dextran amine with the method mentioned above, but the injection site was at T7 and the distal spinal cord was processed.
Statistical analysis
Behavioral and morphological data were analyzed by twotailed Student's t-test. Because the open-field motor scores were measured at different times after injury, they were also analyzed by two-factor repeated measures of analysis of variance.
Results
HpDCs improving functional recovery from SCI Typical paraplegia was observed in all animals after contusion. However, the mice injected with hpDCs and mbpDCs recovered from SCI more rapidly and significantly than the mice injected with PBS. As soon as 7 days after injection (Po0.05, Table 1 ), the differences increased with the passage of time. Twenty eight days after injection, the score of the hpDCs group reached and persisted at the highest plateau, with the score of mbpDCs group at a relatively lower plateau, hpDCs promote recovery from SCI M Liu et al whereas the score of the PBS group reached and persisted at the lowest plateau 35 days after injection (Figure 1 ). Eightyfour days after injection, the scores of the PBS, mbpDCs and hpDCs groups (subgroups of local injection) were 10.0±2.0, 16.3 ± 2.1 and 18.2 ± 1.1, respectively. No significant difference was observed between the locally or peritoneally injected groups at the same time points.
Histological analysis
The spinal cords were removed with the lesion sites in the middle 28, 56, 84 days after injection. All the cords were sectioned longitudinally and stained with hematoxylin and eosin, and observed with light microscopy. The characteristics of the PBS group are described as follows: 28 days after injection, the lesion site was full of debris of tissues, foam cells and the normal longitudinal structure of conduction tracts lost, whereas there was no distinct boundary between the lesion and normal sites (Figure 2a) . Fifty-six days after injection, cysts in the lesion site formed distinct boundary, and the glial bundles extended into the cysts (Figure 2b ). Eighty-four days after injection, the boundary of the cysts formed completely and the glial scar became more compact, whereas there were no tissues in the cysts (Figure 2c ). There was no difference in the pathological change between the mbpDCs and hpDCs groups, but differences were found in the areas of lesion sites and cysts, as well as in the thickness of the glial scar (Table 2) .
Immunohistochemistry
Nestin. The expression of nestin is transiently positive 4 weeks after SCI. In this study, however, immunohistochem- . At 7 days after injection, the scores of the mbpDCs and hpDCs groups were significantly higher than that of the control group (Po0.05). At 28 days after injection, the mbpDCs and hpDCs groups reached higher plateaus (14.8 ± 2.0, 16.2 ± 2.0) more rapidly and significantly than did the phosphatebuffered saline (PBS) group, which reached a lower plateau 35 days after injection (10.0 ± 1.2, Po0.01). The difference between the mbpDCs and hpDCs groups was observed at 28 days after injection (Po0.05).
hpDCs promote recovery from SCI M Liu et al istic fluorescence of nestin and NF showed that there were nestin-positive cells in the hpDCs group until 56 days after injection (Figure 3a) , whereas the PBS or mbpDCs groups were nestin negative since 28 days after injection (Figure 3b ). This fact showed that the expression of nestin was prolonged in the hpDCs group.
Neurofilament. On 28 and 56 days after injection, the axons around the lesion sites were destroyed and debris were phagocytosed, whereas cysts formed and no axon was spared in the lesion sites center. The axons stopped at the wall of the glial scar and never reached into the cyst in the PBS group (Figure 4a) . No difference was observed between the mbpDCs and hpDCs groups (Figure 4b ).
Glial fibrillary acidic protein. On 56 days after injection in the PBS group, cysts formed with a definite edge, and no GFAP þ cells were stained in the cyst. Proliferative, hypertrophic and compact astrocytes were found near the wall of the cyst. The expression of GFAP decreased with the distance to the cyst, and the astrocytes became normal. The expression of GFAP in the hpDCs group was less and slower than that in the DCs group. The distribution of astrocytes was looser than in the DCs group ( Figure 5 ).
Retrograde and antegrade labeling of axons. Retrograde labeling with horseradish peroxidase and antegrade labeling with biotinylated dextran amine of the axons showed that axons stopped at the lesion site and that no difference was observed among the three groups ( Figure 6 ). hpDCs promote recovery from SCI M Liu et al
Discussion
The results of this study show a significant improvement in locomotor function after contusive SCI in mice treated by local or peritoneal injection of bone marrow-derived DCs pulsed in vitro with homogenate protein. The beneficial effect of the treatment was also evident morphologically, with better preservation of neural tissues on histology and a decrease in the sizes of cysts in the spinal cords of treated mice examined by immunohistochemistry. The endogenous autoimmune response can be boosted by innate and adaptive immune manipulations, 13 whereas DCs were found to populate specific areas of the central nervous system, including the meninges and choroid plexus. 14 DCs are potent to initiate specific immune responses. Yoles et al. 15 have found that stimulation of an adaptive immune response against central nervous system self-antigens after an injury is a normal part of the body's own healing mechanism and a central feature of the proposed concept of 'protective autoimmunity.' 16, 17 We show here that function recovery from SCI is improved by implanting hpDCs locally or peritoneally. The locomotor activity of the mice used in the experiment was assessed before treatment, and only mice with a BBB score lower than 2 were used. This homogeneous group of mice was randomly divided into three groups, which were treated with the hpDCs, mbpDCs or PBS, respectively. This approach minimizes the variations in insulting severity among contused mice within the same group and between the treated and control groups. Interestingly, the outcome in the treated mice was different, whereas the mice treated with hpDCs showed the best recovery, whereas only a slight improvement was observed in the control group.
Treatment with mbpDCs or hpDCs has different effects on the injured spinal cord. DCs pulsed with homogenate protein of the spinal cord were more beneficial than mbpDCs, suggesting that hpDCs cause more potent protective immunity reactions. We presume that there is more than one kind of autoantigen in vivo, which is beneficial to neural recovery from SCI, rather than a single antigen, for example, MBP alone. We are designing new experiments to seek out the mechanisms.
Our results showed that vaccination with hpDCs decreased the areas of lesion sites and cysts, as well as reduced the hpDCs promote recovery from SCI M Liu et al density of the glial scar. Glial cells have important functions in the functional recovery from SCI and their number and disposition are both important. The fact that vaccination with hpDCs decreases the density of the glial scar to a relatively low level may reduce the barrier of the glial scar to regrowth of the axons and decrease the inhibitory factors produced by the glial cells, although we do not find the axons growing into glial scars. It is evident that hpDCs improve the functional recovery of neural tissues not only immunologically but also morphologically. 18, 19 The local mechanisms of protection acting on the neural tissues are not understood fully, but increasing data support a key function for resident microglia and infiltrating macrophages in this process. Rapalino et al. 20 thought that the local implantation of activated macrophages into completely transected spinal cords leads to regeneration of severed axons with partial functional recovery of otherwise completely paralyzed rats. The injected activated macrophages are reminiscent of antigen-presenting cells. The findings in this study suggest that the effects of hpDCs on the injured spinal cord are mediated through systemic immune mechanisms, because there were no significant differences among the effects of DCs administered locally or peritoneally to the spinal cord.
Conclusion
The results of this study clearly show a beneficial effect of hpDCs on functional and morphological recovery from SCI in BALB/c mice, and both local and peritoneal injections have the same effect. The results show that hpDCs improve functional recovery and decrease the areas of cysts as well as the density of glial scar. It is of more importance that hpDCs prolong the duration of expression of nestin. HpDCs are more potent than mbpDCs in functional recovery from SCI.
